Cardiac remote patient monitoring has moved from a promising idea to a documented part of cardiovascular care. Cardiology teams now have two things they did not have a few years ago: a formal implementation guide from the American College of Cardiology (ACC) and a growing body of research showing fewer hospital admissions and lower costs for monitored patients. This article covers the ACC Remote Patient Management Workbook, the study in Telemedicine and e-Health that first drew attention to cardiac remote patient monitoring outcomes, and the newer meta-analyses published in 2025 and 2026 that strengthen the case.
Why Cardiac Remote Patient Monitoring Matters Now
Heart failure alone affects roughly 6.7 million U.S. adults, and the Heart Failure Society of America projects that number will reach 8.7 million by 2030. Hypertension, atrial fibrillation, and coronary artery disease add millions more patients who need regular follow-up between visits. Most cardiology practices cannot schedule that many appointments. Cardiac remote patient monitoring fills the gap by sending daily readings, such as weight, blood pressure, heart rate, and oxygen saturation, from the patient’s home to the care team.
The appeal is simple. Decompensation in heart failure usually builds over several days. A two-pound weight gain overnight, a rising resting heart rate, or a falling oxygen level can each signal trouble before the patient feels it. When those numbers reach a nurse the same day, medication can be adjusted by phone. When they do not, the next data point is often an emergency department visit.
Cardiac Remote Patient Monitoring: The ACC Workbook
In 2024, the ACC Innovation Program released the ACC Remote Patient Management (RPM) Workbook. It was written for cardiovascular care teams that want to start or improve a program and are unsure where to begin. Tony Das, MD, FACC, who chaired the writing group, described remote monitoring tools as critical to patient care as the cardiovascular landscape grows more complex.
The workbook addresses the uncertainty many clinicians feel when adding digital health tools to an established practice. It sets out definitions, describes the device categories available, and weighs the clinical uses, benefits, and limits of each approach.
Topics covered in the ACC workbook include:
- Definitions and categories of current RPM technology
- Objectives and the evidence base for cardiac remote patient monitoring
- Readiness questions to answer before launching a program
- Key clinical use cases in cardiovascular care
- Staffing, workflow integration, and the role of artificial intelligence
- Implementation guidance along with coding and billing information
The guide walks through RPM applications for specific conditions, including post-myocardial infarction care, heart failure management, atrial fibrillation monitoring, and cardiac rehabilitation. It is candid about the hard parts too. Data overload, electronic health record integration, patient adherence, and reimbursement complexity all get attention. The authors also recommend auditing any program monthly with random dashboard reviews so quality stays consistent as enrollment grows.
One useful distinction the workbook draws is between guideline-backed monitoring, such as remote follow-up of implanted cardiac devices, and consumer wearables that have no guideline indication and no FDA clearance. For most cardiac remote patient monitoring programs built on blood pressure cuffs, scales, and pulse oximeters, that means choosing FDA-cleared devices and documenting why each patient is being monitored.
The Telemedicine and e-Health Study on Cardiac Patients
The ACC workbook explains how to build a program. A study published in Telemedicine and e-Health shows what one looks like in practice. A regional health network in Virginia enrolled 80 patients with diabetes, congestive heart failure, or both into an RPM program for at least 90 days. The program paired device monitoring with care coordination, health coaching, and referrals for behavioral health and aging-related services.
The results for enrolled cardiovascular patients included:
- A 65% decrease in hospital admissions
- An 85% reduction in hospital observations and related inpatient services
- Fewer readmissions among patients who stayed enrolled longer
- Net savings of $390,296 in claims costs, about 173% of what the program cost to run
- Faster response to patient needs through consistent daily monitoring
The enrollment finding deserves emphasis. Patients who remained in the program for 90 days or more saw the largest drop in readmissions and emergency visits. That points to onboarding, device simplicity, and steady outreach as program design choices that affect outcomes, not just conveniences. Tenovi has written separately about how heart failure RPM programs are structured to keep patients enrolled.
What Newer Research Adds in 2025 and 2026
A single-site study of 80 patients is encouraging. Larger evidence is now available, and it points the same way.
A 2025 meta-analysis in the European Journal of Heart Failure pooled 31 randomized trials covering nearly 12,000 patients for hospitalization outcomes and more than 14,000 for mortality. Remote patient monitoring was associated with a 19% lower odds of death and a 22% lower odds of a first heart failure hospitalization compared with usual care. The authors went further and asked which program components mattered. Programs that included a patient self-management module and an education module reduced heart failure hospitalizations significantly. Adding video calls reduced both heart failure and all-cause hospitalizations.
A 2026 systematic review and trial sequential analysis in Cureus widened the lens to 65 randomized controlled trials and roughly 23,000 participants. Across structured telephone support, non-invasive telemonitoring, and implantable sensors, RPM reduced all-cause mortality by about 9% and lowered heart failure hospitalization. The trial sequential analysis suggested the mortality finding is unlikely to be overturned by future trials. The review also flagged a gap: equity-focused subgroup data remain thin, so programs serving rural or lower-income populations should track their own results closely.
A 2026 survey of 28 French cardiology departments, published in the International Journal of Environmental Research and Public Health, looked at the staff side. Every department rated the effect of RPM on patient care as positive or very positive. About a third reported improved working conditions, and nearly two-thirds reported no change. Only one practice reported a decline. That matters for cardiology groups worried that monitoring will bury nurses in alerts.
Taken together, these studies confirm what the ACC workbook anticipated. Cardiac remote patient monitoring works best when the device data is tied to education, self-management support, and a clinician who responds. The hardware is necessary. It is not sufficient.
Billing Considerations for Cardiac RPM Programs
The ACC workbook devotes a section to reimbursement because sustainable programs need to be funded. Medicare covers remote physiologic monitoring under CPT codes 99453, 99454, 99457, 99458, and 99091. The 2026 Medicare Physician Fee Schedule added CPT 99445, which covers 2 to 15 days of device data in a 30-day period, and CPT 99470, which covers 10 to 19 minutes of treatment management time. Together they allow care teams to monitor patients who do not reach the 16-day threshold, such as those in a short post-discharge window.
The patient-first reading of these codes is the right one. They exist so that a cardiologist can monitor a patient after a hospital stay for exactly as long as the clinical picture requires, and be paid for the clinical work involved. The evidence above shows that work reduces admissions, which is where the cost savings come from.
Reimbursement information is provided for educational purposes only and is not legal, compliance, billing, coding, or reimbursement advice. Coding, coverage, and payment vary by payer and locality and are subject to change. Coverage or payment is not guaranteed; consult applicable payer guidance and qualified advisors. CPT® is a registered trademark of the American Medical Association.
Building a Cardiac Remote Patient Monitoring Program
The research and the ACC guidance converge on a few practical points for any cardiology practice, health system, or RPM company serving cardiac patients.
Start with the right patients. Post-discharge heart failure patients, uncontrolled hypertension, and recent MI are the use cases with the strongest evidence and the clearest clinical protocols.
Keep the devices simple. Patients who have to pair a Bluetooth device, open an app, or connect to Wi-Fi are more likely to stop taking readings. Cellular-connected devices and gateways send data automatically, which supports the longer enrollment the Virginia study tied to better outcomes. This is also how programs reach patients in rural areas with limited broadband.
Pair data with education. The 2025 meta-analysis found that self-management and education modules were among the components that reduced hospitalizations. Daily weight readings do more when the patient understands what a two-pound jump means and who to call.
Plan the clinical response. Decide in advance who reviews alerts, what thresholds trigger a call, and how escalation reaches the physician. Write it down. The ACC recommends monthly audits to make sure the protocol is being followed.
Measure your own results. Track admissions, readmissions, emergency visits, and enrollment duration for monitored patients. Programs that can show reduced hospital admissions in their own population have a much easier time securing continued investment.
Frequently Asked Questions
This section answers common questions cardiology teams and RPM program managers ask about cardiac remote patient monitoring, including which patients benefit, what the ACC recommends, and how reimbursement works.
1) What is cardiac remote patient monitoring?
Cardiac remote patient monitoring is the use of connected medical devices, such as blood pressure monitors, weight scales, pulse oximeters, and ECG patches, to track a patient’s cardiovascular status from home. Readings are transmitted to the care team, who review them and intervene when values move outside a set range.
2) What does the ACC Remote Patient Management Workbook recommend?
The 2024 ACC workbook recommends that cardiovascular practices assess their readiness before launching, choose FDA-cleared devices suited to the condition being monitored, define staffing and alert workflows up front, integrate data into the EHR where possible, and audit the program monthly. It also summarizes the evidence base and current billing codes.
3) Which cardiac conditions benefit most from remote patient monitoring?
Heart failure has the strongest evidence, with multiple meta-analyses showing fewer hospitalizations and lower mortality. Hypertension, post-myocardial infarction recovery, atrial fibrillation, and cardiac rehabilitation are the other use cases the ACC workbook highlights.
4) How much can cardiac remote patient monitoring reduce hospital admissions?
Results depend on the program. The Virginia health network study reported a 65% reduction in admissions and an 85% reduction in related inpatient services. Pooled randomized trial data show a roughly 20% lower odds of first heart failure hospitalization, which is a more conservative estimate across varied program designs.
5) Does Medicare cover cardiac remote patient monitoring?
Yes. Remote physiologic monitoring for chronic or acute cardiac conditions is covered under CPT codes 99453, 99454, 99457, 99458, and 99091. For 2026, CMS added CPT 99445 for 2 to 15 days of data and CPT 99470 for 10 to 19 minutes of management time. Coverage and payment vary by payer and locality.
6) What devices are used in a cardiac remote patient monitoring program?
Most programs use a connected blood pressure monitor, a connected weight scale, and a pulse oximeter. Some add a single-lead ECG device for rhythm monitoring. Cellular-connected devices, or Bluetooth devices paired with a cellular gateway, remove the need for a smartphone or Wi-Fi and are easier for many patients to use every day.
Understanding Cardiac Remote Patient Monitoring
Cardiac remote patient monitoring now rests on two foundations. The ACC Remote Patient Management Workbook gives cardiovascular teams a structured way to plan devices, staffing, workflow, and billing. Research from the Virginia health network study through the 2025 and 2026 meta-analyses shows that monitored cardiac patients are admitted less often, cost less to care for, and in pooled trial data live longer. The programs that perform best combine daily device data with patient education, self-management support, and a clinician who acts on what the data shows. For health systems managing the rising burden of chronic disease, that combination is a practical path forward.
Tenovi provides cellular-connected remote patient monitoring devices and the Tenovi Cellular Gateway to RPM software companies, chronic care management organizations, telehealth platforms, health systems, payers, and pharmacies. Our devices send readings automatically with no app, pairing, or Wi-Fi required, which helps cardiac patients stay enrolled and care teams stay informed. Contact us for a free demo and consultation to see how Tenovi can support your cardiac remote patient monitoring program.
